###begin article-title 0
###xml 72 80 <span type="species:ncbi:9606">Patients</span>
Interaction of Vitamin D Receptor with HLA DRB1*0301 in Type 1 Diabetes Patients from North India
###end article-title 0
###begin p 1
###xml 205 213 <span type="species:ncbi:9606">patients</span>
Conceived and designed the experiments: RR. Performed the experiments: NI AAK. Analyzed the data: NI AAK RR. Contributed reagents/materials/analysis tools: RG AAK RR. Wrote the paper: NI RR. Diagnosed the patients: RG. Provided the clinical data, ages at onset of the disease and blood samples for the study: RG.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Type 1 diabetes (T1D) is a multifactorial autoimmune disorder where interaction and integration of immune response genes along with environmental factors play a role in autoimmune destruction of the insulin producing Pancreatic Beta cells.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 54 58 54 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FokI</italic>
###xml 75 79 75 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BsmI</italic>
###xml 84 88 84 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApaI</italic>
###xml 111 115 111 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TaqI</italic>
###xml 139 157 139 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vitamin D receptor</italic>
###xml 159 162 159 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 188 196 188 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 460 473 460 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1*0301</italic>
###xml 568 571 568 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 618 626 618 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 735 739 735 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBAt</italic>
###xml 744 748 744 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fBAT</italic>
###xml 855 859 855 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBAt</italic>
###xml 864 868 864 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fBAT</italic>
###xml 962 966 962 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fBAT</italic>
###xml 1127 1128 1127 1128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1133 1134 1133 1134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 1148 1161 1148 1161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1*0301</italic>
###xml 1163 1164 1163 1164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1169 1170 1169 1170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 1182 1185 1182 1185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 1219 1222 1219 1222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 1277 1290 1277 1290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1*0301</italic>
###xml 1348 1360 1348 1360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1*030</italic>
###xml 646 654 <span type="species:ncbi:9606">patients</span>
###xml 825 833 <span type="species:ncbi:9606">patients</span>
###xml 906 914 <span type="species:ncbi:9606">patients</span>
###xml 1005 1013 <span type="species:ncbi:9606">patients</span>
We have studied four single nucleotide polymorphisms (FokI site in Exon 2, BsmI and ApaI sites in Intron 8 and TaqI site in exon 9) in the vitamin D receptor (VDR) gene using PCR-RFLP and HLA-DRB1 alleles using PCR and hybridization with sequence specific oligonucleotide probes and studied their interaction using LD based statistics for non-linked loci followed by sequence analysis of the vitamin D response element (VDRE) present in the promoter region of HLA-DRB1*0301. Haplotypes, constructed using SHEsis program for four single nucleotide polymorphisms in the VDR gene, were studied for their interaction with HLA-DRB1 alleles in 233 T1D patients and 191 healthy controls from North India. A significant increase of haplotypes FBAt and fBAT (p<0.02, OR = 1.44 and p<0.002, OR = 3.23 respectively) was observed in the patients. Both the haplotypes FBAt and fBAT were significantly increased in male patients with age at onset less than 18 years; however, fBAT was significantly increased in female patients irrespective of their age at onset. LD based statistics showed significant interaction between the high producer F and T alleles with HLA-DRB1*0301. F and T alleles of VDR have been shown to contribute to VDR mRNA independently. The promoter sequence analysis of HLA-DRB1*0301 showed presence of VDRE involved in higher expression of HLA-DRB1*030, which was confirmed by flow cytometry and real time PCR analysis.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 48 51 48 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 56 59 56 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 122 135 122 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1*0301</italic>
###xml 225 226 225 226 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 227 228 227 228 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 274 283 274 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DRB1*0301</italic>
These data suggest that the interaction between VDR and HLA alleles is mediated by VDRE present in the promoter region of HLA-DRB1*0301 allele, which may be detrimental for the manifestation of T1D in the absence of 1,25-(OH)2D3 in early childhood due to poor expression of DRB1*0301 in the thymus resulting in autoimmunity.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 223 226 223 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Ramachandran1">[1]</xref>
###xml 619 628 619 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DRB1*0301</italic>
###xml 651 659 651 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INS-VNTR</italic>
###xml 701 703 701 703 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 754 757 754 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Rani1">[2]</xref>
###xml 811 834 811 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945; -308 (GA + AA</italic>
###xml 874 885 870 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-6, IL-10</italic>
###xml 890 899 886 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGF-&#946;1</italic>
###xml 976 994 969 983 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF- &#945; -308 GG</italic>
###xml 1032 1041 1021 1026 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFN-&#947;</italic>
###xml 1070 1074 1055 1059 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-6</italic>
###xml 1080 1090 1065 1072 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGF- &#946;1</italic>
###xml 1123 1132 1105 1110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945;</italic>
###xml 1192 1201 1170 1179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DRB1*0301</italic>
###xml 1201 1204 1179 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Kumar1">[3]</xref>
###xml 1327 1351 1305 1329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vitamin D receptor (VDR)</italic>
###xml 1390 1393 1368 1371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 712 720 <span type="species:ncbi:9606">patients</span>
###xml 941 949 <span type="species:ncbi:9606">patients</span>
###xml 1409 1417 <span type="species:ncbi:9606">patients</span>
Type 1 diabetes (T1D) is a multifactorial, autoimmune disorder where the insulin producing pancreatic beta cells are destroyed by one's own immune system. The disorder occurs with an incidence of 10.5/100,000/year in India [1]. T1D develops as a result of complex interaction of many genetic and environmental factors leading to autoimmune destruction of the insulin producing Pancreatic Beta cells. While 20 genomic intervals have been implicated for the manifestation of the disease, role of an intricate network of the products of these genes cannot be ruled out. We have shown earlier that simultaneous presence of DRB1*0301 along with homozygous INS-VNTR class-I was significantly increased (p<10-8) in T1D patients, giving a relative risk of 70.81 [2]. Simultaneous presence of high secretor genotypes of TNF-alpha -308 (GA + AA) along with high secretor genotypes of IL-6, IL-10 and TGF-beta1 were also significantly increased in T1D patients. Low secretor genotype of TNF- alpha -308 GG along with low secretor genotypes of IFN-gamma, high secretor genotypes of IL-6, and TGF- beta1 were protective. This effect of TNF-alpha high secretor genotype was independent of predisposing HLA-DRB1*0301[3]. To further understand the intricate network of genes regulating the immune responses, we have studied the interaction of vitamin D receptor (VDR) polymorphic alleles with predisposing HLA alleles in T1D patients using Linkage Disequilibrium (LD) based statistics between two unlinked loci.
###end p 9
###begin p 10
###xml 134 137 134 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Evans1">[4]</xref>
###xml 187 188 187 188 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 189 190 189 190 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 262 263 262 263 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 264 265 264 265 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 481 482 481 482 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 542 543 542 543 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 544 545 544 545 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 562 565 562 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Boonstra1">[5]</xref>
###xml 628 629 628 629 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 630 631 630 631 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 691 692 691 692 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 693 694 693 694 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 849 852 849 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Takeuchi1">[6]</xref>
###xml 863 864 863 864 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 865 866 865 866 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 962 966 962 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-2</italic>
###xml 966 969 966 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Bhalla1">[7]</xref>
###xml 971 974 971 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Alroy1">[8]</xref>
###xml 976 985 976 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFN-&#947;</italic>
###xml 985 988 981 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Cippitelli1">[9]</xref>
###xml 990 996 986 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GM-CSF</italic>
###xml 996 1000 992 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Lemire1">[10]</xref>
###xml 1005 1010 1001 1006 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-12</italic>
###xml 1010 1014 1006 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-DAmbrosio1">[11]</xref>
###xml 1083 1087 1076 1080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Cantorna1">[12]</xref>
###xml 1233 1236 1226 1229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Boonstra1">[5]</xref>
###xml 1256 1257 1249 1250 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1258 1259 1251 1252 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1310 1313 1303 1306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 1365 1369 1358 1362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Rigby1">[13]</xref>
###xml 1371 1375 1364 1368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Skjodt1">[14]</xref>
###xml 1348 1353 <span type="species:ncbi:9606">human</span>
Vitamin D Receptor (VDR) is a ligand dependent transcription factor that belongs to the super family of the Nuclear Hormone Receptors [4]. The ligand for VDR is Vitamin D3 i.e., 1,25-(OH)2D3 which mediates its biological actions through VDR. Binding of 1,25-(OH)2D3 induces conformational changes in VDR which promotes its hetero-dimerization with Retinoid X Receptor (RXR), followed by translocation of this complex into the nucleus. The RXR-VDR heterodimer binds to the vitamin D3 responsive elements (VDRE) in promoter regions of 1,25-(OH)2D3 responsive genes[5], which in turn results in the regulatory function of 1,25-(OH)2D3. In the absence of classical responsive elements, 1,25-(OH)2D3 may control the expression of some genes like cytokine genes by targeting inducible transcription factors like NFAT in IL-2 in a sequence specific manner [6]. 1,25-(OH)2D3 has been shown to have an important immuno-modulatory role since it represses transcription of IL-2[7], [8], IFN-gamma[9], GM-CSF[10] and IL-12[11] and up regulates the production of Th2 cytokines IL-4 and TGF-beta1 [12], thereby inhibiting the overall Th1 responses. It has been shown to enhance the development of TH2 cells via a direct effect on naive CD-4 cells [5]. Besides, 1,25-(OH)2D3 has also been shown to modulate the expression of HLA class-II alleles on monocytes and human bone cells [13], [14]
###end p 10
###begin p 11
###xml 40 41 40 41 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 42 43 42 43 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 277 278 277 278 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 279 280 279 280 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 324 328 324 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Mathieu1">[15]</xref>
###xml 329 333 329 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Zella1">[18]</xref>
###xml 448 452 448 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Hypponen1">[19]</xref>
###xml 454 458 454 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Jones1">[20]</xref>
###xml 475 476 475 476 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 477 478 477 478 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 516 519 516 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 588 591 588 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MHC</italic>
###xml 781 785 781 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FokI</italic>
###xml 805 809 805 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Gross1">[21]</xref>
###xml 837 841 837 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BsmI</italic>
###xml 841 845 841 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Morrison1">[22]</xref>
###xml 872 876 872 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApaI</italic>
###xml 876 880 876 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Faraco1">[23]</xref>
###xml 923 927 923 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Durrin1">[24]</xref>
###xml 942 946 942 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TaqI</italic>
###xml 1002 1005 1002 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 1031 1034 1031 1034 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 1069 1073 1069 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Zhao1">[25]</xref>
###xml 1141 1144 1141 1144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MHC</italic>
###xml 1247 1251 1247 1251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Ramagopalan1">[26]</xref>
###xml 7 11 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 258 262 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 349 355 <span type="species:ncbi:9606">humans</span>
In NOD mice, administration of 1,25-(OH)2D3 before the onset of Insulitis, has been effectively shown to prevent the disease progression. However, this treatment was found to be ineffective when Insulitis had already been established. Treatment of adult NOD mice with 1,25-(OH)2D3 analog has also been shown to be effective [15]-[18]. Similarly, in humans, vitamin D supplementation in early childhood has been shown to reduce the incidence of T1D [19], [20]. Since 1,25-(OH)2D3 is a VDR ligand, we have studied the VDR gene polymorphisms and their interaction with the most predisposing MHC alleles to investigate their role, if any, in the pathophysiology of T1D. The VDR single nucleotide polymorphisms (SNPs) studied include the T>C SNP in exon2 initiation codon detected with FokI restriction enzyme [21], the A>G SNP detected with BsmI[22] and G>T SNP detected with ApaI[23] located in Intron 8, and a silent C>T SNP [24] detected with TaqI, located in Exon 9. We studied the interaction between VDR alleles and predisposing HLA alleles using LD based statistics [25] and subsequently sequenced the promoter region of the predisposing MHC allele to detect the VDRE sequence which has been shown to modulate the expression of the HLA alleles [26], suggesting the functional implications of the statistically significant interaction.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
###xml 4 20 4 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FokI, BsmI, ApaI</italic>
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TaqI</italic>
###xml 62 70 <span type="species:ncbi:9606">Patients</span>
VDR FokI, BsmI, ApaI and TaqI Genotypes and Haplotypes in T1D Patients
###end title 13
###begin p 14
###xml 0 7 0 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008023-t001">Table 1</xref>
###xml 33 49 33 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FokI, BsmI, ApaI</italic>
###xml 54 58 54 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TaqI</italic>
###xml 70 81 70 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008023-g001">figure 1A&#8211;D</xref>
###xml 142 146 142 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FokI</italic>
###xml 148 152 148 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BsmI</italic>
###xml 157 161 157 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TaqI</italic>
###xml 256 260 256 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApaI</italic>
###xml 398 402 398 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApaI</italic>
###xml 407 411 407 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TaqI</italic>
###xml 438 442 438 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FokI</italic>
###xml 535 539 535 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BsmI</italic>
###xml 94 101 <span type="species:ncbi:9606">patient</span>
###xml 223 231 <span type="species:ncbi:9606">patients</span>
###xml 311 319 <span type="species:ncbi:9606">patients</span>
###xml 415 423 <span type="species:ncbi:9606">patients</span>
###xml 483 490 <span type="species:ncbi:9606">patient</span>
###xml 580 587 <span type="species:ncbi:9606">patient</span>
Table 1 shows the frequencies of FokI, BsmI, ApaI and TaqI genotypes (figure 1A-D) in the T1D patient group as compared to the control group. FokI, BsmI and TaqI sites were found to be in Hardy Weinberg equilibrium both in patients as well as controls and ApaI site was in Hardy Weinberg disequilibrium in both patients and controls. While there were no significant differences in the genotypes of ApaI and TaqI in patients and controls. FokI 'ff' was significantly increased in the patient group as compared to controls (p<0.047) and BsmI 'bb' was significantly decreased in the patient group (p<0.04). However, these differences did not remain significant after Boneferroni's correction.
###end p 14
###begin title 15
###xml 128 144 128 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FokI, BsmI, ApaI</italic>
###xml 150 154 150 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TaqI</italic>
The genotypes for the four SNPs were determined by PCR amplification and restriction digestion of the PCR products with enzymes FokI, BsmI, ApaI, and TaqI.
###end title 15
###begin p 16
###xml 95 128 95 128 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;AGCTGGCCCTGGCACTGACTCTTGCTCT 3&#8242;</named-content>
###xml 133 165 133 165 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;ATGGAAACACCTTGCTTCTTCTCCCTC 3&#8242;</named-content>
###xml 602 637 590 625 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;CAACCAAGACTACAAGTACCGCGTCAGTGA 3&#8242;</named-content>
###xml 642 670 630 658 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;AACCAGCGGGAAGAGGTCAAGGG 3&#8242;</named-content>
###xml 1104 1132 1080 1108 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; CAGAGCATGGACAGGGAGCAAG 3&#8242;</named-content>
###xml 1137 1168 1113 1144 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; GCAACTCCTCATGGCTGAGGTCTCA 3&#8242;</named-content>
###xml 1597 1624 1561 1588 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;CAGAGCATGGACAGGGAGCAAG 3&#8242;</named-content>
###xml 1629 1659 1593 1623 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;GCAACTCCTCATGGCTGAGGTCTCA 3&#8242;</named-content>
A: Fok1 digestion: SNP C/T in exon 2 was studied by amplifying a 265 bp fragment using primers 5'AGCTGGCCCTGGCACTGACTCTTGCTCT 3' and 5'ATGGAAACACCTTGCTTCTTCTCCCTC 3' with 68degreesC as annealing temperature and digestion by fok1 at 37degreesC for 3 hours. Presence of restriction site is denoted by 'f' while absence of restriction is denoted by 'F'. Results show FF (CC) i.e., a 265 bp band or Ff (CT) i.e., 265 bp, 196 bp and 69 bp, bands, ff (TT) i.e., 196 bp and 69 bp bands. M is the100 bp ladder. B: Bsm 1 digestion: SNP A/G in Intron 8 was studied by amplifying an 825 bp fragment using primers 5'CAACCAAGACTACAAGTACCGCGTCAGTGA 3' and 5'AACCAGCGGGAAGAGGTCAAGGG 3' with 65degreesC as annealing temperature and digestion by Bsm1 at 65degreesC for one hour. Presence of restriction site is denoted as 'b' and absence of restriction is denoted by 'B'. The results show BB (AA) i.e., 825 bp band, Bb (AG) i.e., 825 bp, 650 bp and 175 bp and bands and bb (GG) 650 bp and 175 bp bands. M is 25 bp ladder. C: Apa 1 digestion: SNP T/G in Intron 8 was studied by amplifying an 740 bp fragment using primers 5' CAGAGCATGGACAGGGAGCAAG 3' and 5' GCAACTCCTCATGGCTGAGGTCTCA 3' with 65degreesC as annealing temperature and digestion by Apa1 at 37degreesC for one hour. Presence of restriction site is denoted as 'a; and absence of restriction is denoted by 'A'. The results show AA (TT) i.e., 740 bp band, Aa (TG) i.e., 740 bp, 520 bp and 220 bp bands and aa (GG) 520 bp and 220 bp bands. M is 100 bp ladder. D: Taq 1 digestion: SNP T/C in exon 9 was studied by amplifying an 740 bp fragment using primers 5'CAGAGCATGGACAGGGAGCAAG 3' and 5'GCAACTCCTCATGGCTGAGGTCTCA 3' with 65degreesC as annealing temperature and digestion by Taq1 at 65degreesC for one hour. Presence of restriction site is denoted as 't' and absence of restriction is denoted by 'T'. The results show TT (TT) i.e., 495 bp and 245 bp bands Tt (TC) i.e., 495 bp, 290 bp, 245 bp and 205 bp bands and tt (CC) 290 bp, 245 bp and 205 bp bands. M is 100 bp ladder.
###end p 16
###begin title 17
###xml 38 41 38 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 50 65 50 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fok1, Bsm1, Apa</italic>
###xml 70 74 70 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq1</italic>
###xml 88 96 <span type="species:ncbi:9606">patients</span>
Comparison of genotype frequencies of VDR SNPs at Fok1, Bsm1, Apa and Taq1 sites in T1D patients with controls.
###end title 17
###begin p 18
Corrected p (pc) value is not significant.
###end p 18
###begin p 19
#Calculated using Fisher's exact test.
###end p 19
###begin p 20
@HWE p value calculated using SHEsis program.
###end p 20
###begin p 21
###xml 139 143 139 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Shi1">[27]</xref>
###xml 341 348 341 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008023-t002">Table 2</xref>
###xml 523 527 523 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FokI</italic>
###xml 584 594 584 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BsmI, ApaI</italic>
###xml 599 603 599 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TaqI</italic>
###xml 657 661 657 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BsmI</italic>
###xml 694 698 694 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApaI</italic>
###xml 703 707 703 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TaqI</italic>
###xml 744 748 744 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApaI</italic>
###xml 776 780 776 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TaqI</italic>
###xml 1003 1007 1003 1007 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBAt</italic>
###xml 1012 1016 1012 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fBAT</italic>
###xml 1099 1103 1099 1103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fBAt</italic>
###xml 93 101 <span type="species:ncbi:9606">patients</span>
###xml 395 403 <span type="species:ncbi:9606">patients</span>
###xml 874 882 <span type="species:ncbi:9606">patients</span>
###xml 1053 1061 <span type="species:ncbi:9606">patients</span>
Haplotype analysis was carried out for the four restriction sites studied in the VDR gene in patients and controls using SHEsis program () [27]. Additionally, Famhap () was used to confirm the frequencies of the haplotypes. Since both Famhap and SHEsis were giving similar results, we carried out the rest of the analysis using SHEsis only. Table 2 shows the haplotype frequencies of VDR in T1D patients and controls. The software was instructed to drop frequencies less than 0.03 in the analysis. The analysis showed that FokI site was in a very weak linkage disequilibium (LD) with BsmI, ApaI and TaqI with D' values of 0.004, 0.01 and 0.04 respectively. BsmI, however, was in strong LD with ApaI and TaqI with D' values of 0.91 and 0.93 and ApaI was also in strong LD with TaqI with a D' value of 0.97. Significant differences in terms of haplotypes was observed between patients and controls with a global chi-square of 20.9 for 6 degrees of freedom with a p value of 0.002. Individually, haplotype FBAt and fBAT were significantly increased in T1D patients (p<0.02 and <0.001 respectively) and fBAt was significantly reduced in them as compared to controls (p<0.036).
###end p 21
###begin title 22
###xml 23 39 23 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fok1, Apa1, Bsm1</italic>
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq1</italic>
###xml 75 79 75 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Shi1">[27]</xref>
Haplotype Analysis for Fok1, Apa1, Bsm1 and Taq1 loci using SHEsis software[27]. ().
###end title 22
###begin p 23
Haplotype Frequencies less than 0.03 have not been shown in the analysis.
###end p 23
###begin p 24
###xml 46 47 46 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
95% C.I. = 95% confidence interval. Global Chi2 = 20.9 with Pearson's p value = 0.002.
###end p 24
###begin p 25
Linkage disequilibrium test using SHEsis (D').
###end p 25
###begin p 26
###xml 4 22 4 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fok1-Bsm1&#8202;=&#8202;0.004.</italic>
###xml 22 40 22 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fok1-Apa1&#8202;=&#8202;0.010,</italic>
###xml 40 57 40 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fok1-Taq1&#8202;=&#8202;0.04,</italic>
###xml 57 74 57 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bsm1-Apa1&#8202;=&#8202;0.91,</italic>
###xml 74 91 74 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bsm1-Taq1&#8202;=&#8202;0.93,</italic>
###xml 91 108 91 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apa1-Taq1&#8202;=&#8202;0.97.</italic>
D': Fok1-Bsm1 = 0.004.Fok1-Apa1 = 0.010,Fok1-Taq1 = 0.04,Bsm1-Apa1 = 0.91,Bsm1-Taq1 = 0.93,Apa1-Taq1 = 0.97.
###end p 26
###begin title 27
###xml 19 38 19 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FokI-BsmI-ApaI-TaqI</italic>
Association of VDR FokI-BsmI-ApaI-TaqI Haplotypes with Age at Onset
###end title 27
###begin p 28
###xml 179 186 179 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008023-t003">Table 3</xref>
###xml 292 296 292 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fBAT</italic>
###xml 301 305 301 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBAt</italic>
###xml 443 447 443 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FbaT</italic>
###xml 80 88 <span type="species:ncbi:9606">patients</span>
###xml 339 347 <span type="species:ncbi:9606">patients</span>
###xml 594 602 <span type="species:ncbi:9606">patients</span>
To study if the VDR haplotypes are associated with age at onset, we divided the patients into two groups adult onset i.e., above 18 and young onset as below or equal to 18 years (Table 3 shows data on 223 samples in whom the exact age at onset was known). The analysis showed that haplotypes fBAT anf FBAt to be significantly increased in patients who developed diabetes before 18 years of age (p<0.0002 and 0.0077 respectively) and haplotype FbaT seemed to be protective from younger onset of T1D (p<0.037). However, adult onset was not significantly associated with any VDR haplotypes in T1D patients.
###end p 28
###begin title 29
###xml 55 63 <span type="species:ncbi:9606">patients</span>
Association of VDR haplotypes with age at onset in T1D patients.
###end title 29
###begin p 30
###xml 53 58 <span type="species:ncbi:9606">child</span>
Adult onset was considered above 18 years of age and child onset as 18 years or below 18 years. The two groups were compared with controls using SHEsis software.
###end p 30
###begin p 31
###xml 33 41 <span type="species:ncbi:9606">patients</span>
Linkage Disequilibrium tests for patients below 18 years of age (SHEsis).
###end p 31
###begin p 32
###xml 4 13 4 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fok1-Bsm1</italic>
###xml 23 32 23 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fok1-Apa1</italic>
###xml 42 51 42 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fok1-Taq1</italic>
###xml 61 70 61 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bsm1-Apa1</italic>
###xml 80 90 80 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bsm1-Taq 1</italic>
###xml 100 109 100 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apa1-Taq1</italic>
D': Fok1-Bsm1 = 0.048, Fok1-Apa1 = 0.005, Fok1-Taq1 = 0.054, Bsm1-Apa1 = 0.914, Bsm1-Taq 1 = 0.949, Apa1-Taq1 = 0.955.
###end p 32
###begin p 33
###xml 33 41 <span type="species:ncbi:9606">patients</span>
Linkage Disequilibrium tests for patients above 18 years of age (SHEsis).
###end p 33
###begin p 34
###xml 4 13 4 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fok1-Bsm1</italic>
###xml 23 32 23 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fok1-Apa1</italic>
###xml 42 51 42 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fok1-Taq1</italic>
###xml 61 70 61 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bsm1-Apa1</italic>
###xml 80 90 80 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bsm1-Taq 1</italic>
###xml 99 108 99 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apa1-Taq1</italic>
D': Fok1-Bsm1 = 0.004, Fok1-Apa1 = 0.009, Fok1-Taq1 = 0.104, Bsm1-Apa1 = 0.886, Bsm1-Taq 1 = 0.93, Apa1-Taq1 = 0.946.
###end p 34
###begin title 35
###xml 19 38 19 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FokI-BsmI-ApaI-TaqI</italic>
###xml 86 94 <span type="species:ncbi:9606">Patients</span>
Association of VDR FokI-BsmI-ApaI-TaqI Haplotypes with Gender and Age at Onset of T1D Patients
###end title 35
###begin p 36
###xml 189 196 189 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008023-t004">Table 4</xref>
###xml 274 278 274 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fBAT</italic>
###xml 391 395 391 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBAt</italic>
###xml 496 500 496 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FbaT</italic>
###xml 583 587 583 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fBAt</italic>
###xml 936 940 936 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBAt</italic>
###xml 945 949 945 949 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fBAT</italic>
###xml 1096 1100 1096 1100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBAT</italic>
###xml 1267 1270 1267 1270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 1398 1402 1398 1402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fBAT</italic>
###xml 1521 1525 1521 1525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FbaT</italic>
###xml 110 118 <span type="species:ncbi:9606">patients</span>
###xml 317 325 <span type="species:ncbi:9606">patients</span>
###xml 537 545 <span type="species:ncbi:9606">patients</span>
###xml 622 630 <span type="species:ncbi:9606">patients</span>
###xml 679 687 <span type="species:ncbi:9606">patients</span>
###xml 698 706 <span type="species:ncbi:9606">patients</span>
###xml 761 769 <span type="species:ncbi:9606">patients</span>
###xml 987 995 <span type="species:ncbi:9606">patients</span>
###xml 1150 1158 <span type="species:ncbi:9606">patients</span>
###xml 1290 1298 <span type="species:ncbi:9606">patients</span>
###xml 1434 1442 <span type="species:ncbi:9606">patients</span>
###xml 1562 1570 <span type="species:ncbi:9606">patients</span>
To study if this association of VDR haplotypes had any gender bias, comparisons were done between female/male patients and female/male controls and also with all controls (female + males). Table 4 shows the gender-wise analysis of VDR haplotype using SHEsis software. While fBAT was significantly increased in female patients as compared to controls (both female controls and all controls), FBAt was significantly increased in males as compared to controls (both male controls and all controls). FbaT was significantly reduced in female patients when compared to female controls and fBAt was significantly reduced in male patients as compared to controls. A comparison of female patients with male patients did not reveal any significant differences. Since the patients with younger age at onset were showing significant differences, we analysed the data with respect to age at onset in the two genders (data not shown). The haplotypes FBAt and fBAT were significantly increased in male patients below the age at onset of 18 years as compared to controls (p<0.0024 and p<0.0017 respectively) and FBAT was significantly reduced (p<0.0038) in the male patients below the age at onset of 18 years as compared to controls. No significant differences were observed in the VDR haplotypes of male patients with age at onset above 18 years when compared to controls. However, in the females, the haplotype fBAT was significantly increased in patients irrespective of their age at onset whether early or adult onset and haplotype FbaT was significantly reduced in female patients with less than 18years age at onset.
###end p 36
###begin title 37
###xml 64 72 <span type="species:ncbi:9606">patients</span>
###xml 145 153 <span type="species:ncbi:9606">patients</span>
Comparisons of frequencies of VDR haplotypes in male and female patients with male and female controls, all controls and between male and female patients using SHEsis software.
###end title 37
###begin p 38
HF = Haplotype frequency.
###end p 38
###begin p 39
###xml 40 48 <span type="species:ncbi:9606">patients</span>
Linkage Disequilibrium tests for Female patients using SHEsis software.
###end p 39
###begin p 40
###xml 4 13 4 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fok1-Bsm1</italic>
###xml 23 32 23 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fok1-Apa1</italic>
###xml 42 51 42 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fok1-Taq1</italic>
###xml 61 70 61 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bsm1-Apa1</italic>
###xml 78 88 78 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bsm1-Taq 1</italic>
###xml 98 107 98 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apa1-Taq1</italic>
D': Fok1-Bsm1 = 0.066, Fok1-Apa1 = 0.042, Fok1-Taq1 = 0.048, Bsm1-Apa1 = 0.9, Bsm1-Taq 1 = 0.966, Apa1-Taq1 = 0.946.
###end p 40
###begin p 41
###xml 38 46 <span type="species:ncbi:9606">patients</span>
Linkage Disequilibrium tests for Male patients using SHEsis software.
###end p 41
###begin p 42
###xml 4 13 4 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fok1-Bsm1</italic>
###xml 23 32 23 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fok1-Apa1</italic>
###xml 41 50 41 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fok1-Taq1</italic>
###xml 60 69 60 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bsm1-Apa1</italic>
###xml 79 89 79 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bsm1-Taq 1</italic>
###xml 99 108 99 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apa1-Taq1</italic>
D': Fok1-Bsm1 = 0.015, Fok1-Apa1 = 0.03, Fok1-Taq1 = 0.014, Bsm1-Apa1 = 0.898, Bsm1-Taq 1 = 0.923, Apa1-Taq1 = 0.957.
###end p 42
###begin title 43
###xml 28 31 28 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 61 64 61 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
Gene to Gene Interaction of VDR Haplotypes with Predisposing HLA Alleles
###end title 43
###begin p 44
###xml 357 360 357 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 369 414 369 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DRB1*0301, DRB1*0401, DRB1*0402 and DRB1*0405</italic>
###xml 426 429 426 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DR3</italic>
###xml 460 467 460 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008023-t005">Table 5</xref>
###xml 553 563 553 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBAT, FbaT</italic>
###xml 725 729 725 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DRB1</italic>
###xml 829 833 829 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DRB1</italic>
###xml 892 911 892 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBAt, fBAT and fbaT</italic>
###xml 949 957 949 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 979 986 979 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008023-t005">table 5</xref>
###xml 505 513 <span type="species:ncbi:9606">patients</span>
###xml 619 627 <span type="species:ncbi:9606">patients</span>
###xml 675 683 <span type="species:ncbi:9606">patients</span>
Based on the SHEsis and Famhap analysis, haplotypes were constructed manually for each sample. The haplotype with the highest frequency as calculated by SHEsis was constructed from the genotype of each sample and the second haplotype was constructed by subtraction of the first haplotype. Simultaneous presence of different haplotypes with the predisposing HLA alleles DRB1*0301, DRB1*0401, DRB1*0402 and DRB1*0405 (listed as DR3 for the sake of simplicity in Table 5 which includes all these alleles) in patients was studied. Interestingly, haplotypes FBAT, FbaT, whose frequencies were not significantly different in patients and controls, showed a significant increase in patients when present along with the predisposing DRB1 alleles while the same haplotypes were protective when associated with non-predisposing alleles of DRB1. Similar results were obtained with other haplotypes like FBAt, fBAT and fbaT in association with the predisposing HLA-DRB1 alleles, as shown in table 5.
###end p 44
###begin title 45
###xml 82 83 82 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="nt120">*</xref>
###xml 89 90 89 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="nt120">*</xref>
###xml 96 97 96 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="nt120">*</xref>
###xml 106 107 106 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="nt120">*</xref>
Simultaneous presence of different VDR haplotypes along with predisposing HLA-DRB1*0301, *0401, *0402 and *0405 alleles.
###end title 45
###begin p 46
###xml 80 83 80 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DR3</italic>
No. shows the number of individual positive for the indicated VDR haplotype and DR3 allele.
###end p 46
###begin p 47
###xml 51 72 51 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DRB1*0301,*0401,*0402</italic>
###xml 77 82 77 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*0405</italic>
#DR3+ve includes all the Predisposing Alleles i.e. DRB1*0301,*0401,*0402 and *0405.
###end p 47
###begin p 48
Corrected P(pc) value is significant.
###end p 48
###begin p 49
Corrected P(pc) value is not significant.
###end p 49
###begin p 50
###xml 83 86 83 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 108 116 108 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 361 368 361 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008023-t006">Table 6</xref>
###xml 402 411 402 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR, FbaT</italic>
###xml 416 420 416 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBAT</italic>
###xml 474 478 474 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fbaT</italic>
###xml 635 662 635 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1*0301, *0401, *0402</italic>
###xml 667 672 667 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*0405</italic>
###xml 704 712 704 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008023-t005">tables 5</xref>
###xml 713 713 713 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008023-t006"/>
###xml 713 714 713 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008023-t007">7</xref>
###xml 839 840 839 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 851 855 851 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TaqI</italic>
###xml 894 904 894 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FokI, BsmI</italic>
###xml 909 913 909 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApaI</italic>
###xml 1031 1038 1031 1038 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DR3</italic>
###xml 220 228 <span type="species:ncbi:9606">patients</span>
###xml 465 473 <span type="species:ncbi:9606">patients</span>
###xml 526 534 <span type="species:ncbi:9606">patients</span>
###xml 723 731 <span type="species:ncbi:9606">patients</span>
These results prompted us to study the interaction between two unlinked loci i.e., VDR and the predisposing HLA-DRB1 alleles since it was crucial to study the difference in LD patterns of these two unlinked loci between patients and controls. For this kind of analysis we used LD based statistics as described by Zhao et al (22). The analysis has been shown in Table 6. Two most frequent haplotypes of VDR, FbaT and FBAT and a relatively less frequent haplotype in patients fbaT do not show any significant difference between patients and controls when studied by themselves. However, when studied in association with the predisposing HLA-DRB1*0301, *0401, *0402 and *0405 collectively (listed as DR3 in tables 5-7) in T1D patients, these VDR haplotypes show significant linkage disequilibrium. Since all these haplotypes had consistently T allele at TaqI site and either of the two alleles at FokI, BsmI and ApaI sites, in order to decipher which alleles were actually involved, we studied the LD pattern between the predisposing HLA-DR3 with each of these alleles at the four SNP sites separately.
###end p 50
###begin title 51
###xml 194 201 194 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008023-t006">table 6</xref>
LD based statistics to study the linkage disequilibrium between two unlinked loci (VDR haplotypes and predisposing HLA-DRB1*0301, *0401, *0402 and *0405 alleles shown collectively as DR3 in the table 6).
###end title 51
###begin p 52
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DR3+ve</italic>
###xml 50 71 50 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DRB1*0301,*0401,*0402</italic>
###xml 76 81 76 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*0405</italic>
DR3+ve includes all the Predisposing Alleles i.e. DRB1*0301,*0401,*0402 and *0405.
###end p 52
###begin p 53
###xml 5 6 1 2 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
###xml 13 14 5 6 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 17 18 9 10 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
###xml 21 22 13 14 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
deltaA, deltaN, VA, VN and T1 calculated as shown in statistical methods.
###end p 53
###begin p 54
###xml 15 18 15 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DR3</italic>
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBAT</italic>
###xml 39 47 39 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBAT-DR3</italic>
###xml 57 61 57 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBAt</italic>
###xml 70 78 70 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBAt-DR3</italic>
###xml 87 91 87 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FbaT</italic>
###xml 101 109 101 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FbaT-DR3</italic>
###xml 119 123 119 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fBAT</italic>
###xml 133 141 133 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fBAT-DR3</italic>
###xml 151 155 151 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fBAt</italic>
###xml 165 173 165 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fBAt-DR3</italic>
###xml 182 186 182 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fbaT</italic>
###xml 196 204 196 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fbaT-DR3</italic>
###xml 229 232 229 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DR3</italic>
###xml 242 246 242 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBAT</italic>
###xml 256 264 256 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBAT-DR3</italic>
###xml 275 279 275 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBAt</italic>
###xml 289 297 289 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBAt-DR3</italic>
###xml 307 311 307 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FbaT</italic>
###xml 321 329 321 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FbaT-DR3</italic>
###xml 339 343 339 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fBAT</italic>
###xml 353 361 353 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fBAT-DR3</italic>
###xml 372 376 372 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fBAt</italic>
###xml 386 394 386 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fBAt-DR3</italic>
###xml 405 409 405 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fbaT</italic>
###xml 422 430 422 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fbaT-DR3</italic>
###xml 467 470 467 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 512 519 512 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008023-t002">Table 2</xref>
###xml 647 650 647 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 668 675 668 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008023-t002">Table 2</xref>
###xml 216 224 <span type="species:ncbi:9606">patients</span>
Frequencies of DR3 = 0.6, FBAT = 0.12, FBAT-DR3 = 0.107, FBAt = 0.33, FBAt-DR3 = 0.24, FbaT = 0.264, FbaT-DR3 = 0.216, fBAT = 0.088, fBAT-DR3 = 0.075, fBAt = 0.034, fBAt-DR3 = 0.03, fbaT = 0.079, fbaT-DR3 = 0.062 in patients and DR3 = 0.107, FBAT = 0.118, FBAT-DR3 = 0.0183, FBAt = 0.233, FBAt-DR3 = 0.055, FbaT = 0.369, FbaT-DR3 = 0.063, fBAT = 0.052, fBAT-DR3 = 0.0157, fBAt = 0.099, fBAt-DR3 = 0.0236, fbaT = 0.026 and fbaT-DR3 = 0 in controls. Frequencies of the VDR haplotypes are marginally different from Table 2 as these have been calculated from the reconstructed haplotypes based on SHEsis program to study interaction with predisposing HLA alleles, whereas Table 2 shows the frequencies as calculated by SHEsis analysis.
###end p 54
###begin title 55
LD based statistics to study the linkage disequilibrium between two unlinked loci (VDR alleles F/f, B/b, A/a and T/t and predisposing HLA-DRB1*0301, *0401, *0402 and *0405 alleles shown collectively as DR3 in the table).
###end title 55
###begin p 56
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DR3+ve</italic>
###xml 50 71 50 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DRB1*0301,*0401,*0402</italic>
###xml 76 81 76 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*0405</italic>
DR3+ve includes all the Predisposing Alleles i.e. DRB1*0301,*0401,*0402 and *0405.
###end p 56
###begin p 57
###xml 5 6 1 2 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
###xml 13 14 5 6 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 17 18 9 10 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
###xml 21 22 13 14 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
deltaA, deltaN, VA, VN and T1 calculated as shown in statistical methods.
###end p 57
###begin p 58
###xml 15 18 15 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DR3</italic>
###xml 26 27 26 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F-DR3</italic>
###xml 50 51 50 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</italic>
###xml 60 65 60 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f-DR3</italic>
###xml 74 75 74 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 84 89 84 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B-DR3</italic>
###xml 99 100 99 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 109 114 109 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b-DR3</italic>
###xml 124 125 124 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 135 140 135 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A-DR3</italic>
###xml 149 150 149 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 160 165 160 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a-DR3</italic>
###xml 175 176 175 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 186 191 186 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T-DR3</italic>
###xml 201 202 201 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 212 217 212 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t-DR3</italic>
###xml 242 245 242 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DR3</italic>
###xml 255 256 255 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 265 270 265 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F-DR3</italic>
###xml 280 281 280 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</italic>
###xml 290 295 290 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f-DR3</italic>
###xml 305 306 305 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 315 320 315 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B-DR3</italic>
###xml 330 331 330 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 340 345 340 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b-DR3</italic>
###xml 355 356 355 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 365 370 365 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A-DR3</italic>
###xml 380 381 380 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 391 396 391 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a-DR3</italic>
###xml 406 407 406 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 415 420 415 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T-DR3</italic>
###xml 431 432 431 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 441 446 441 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t-DR3</italic>
###xml 487 490 487 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 529 536 529 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008023-t001">Table 1</xref>
###xml 601 609 601 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 229 237 <span type="species:ncbi:9606">patients</span>
###xml 618 626 <span type="species:ncbi:9606">patients</span>
Frequencies of DR3 = 0.6, F = 0.76, F-DR3 = 0.519 f = 0.23, f-DR3 = 0.18, B = 0.59, B-DR3 = 0.425, b = 0.41, b-DR3 = 0.315, A = 0.642, A-DR3 = 0.46, a = 0.358, a-DR3 = 0.273, T = 0.624, T-DR3 = 0.444, t = 0.376, t-DR3 = 0.275 in patients and DR3 = 0.107, F = 0.78, F-DR3 = 0.105, f = 0.21, f-DR3 = 0.047, B = 0.52, B-DR3 = 0.086, b = 0.48, b-DR3 = 0.065, A = 0.59, A-DR3 = 0.094, a = 0.411, a-DR3 = 0.065, T = 0.66 T-DR3 = 0.0942, t = 0.34, t-DR3 = 0.065 in controls. Frequencies of the VDR alleles are marginally different from Table 1 depending on which samples were typed for all the four loci and HLA-DRB1 in both patients and controls.
###end p 58
###begin p 59
###xml 0 7 0 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008023-t007">Table 7</xref>
###xml 36 52 36 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FokI, BsmI, ApaI</italic>
###xml 57 61 57 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TaqI</italic>
###xml 88 125 88 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1*0301, *0401, *0402 and *0405</italic>
###xml 144 152 144 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008023-t005">tables 5</xref>
###xml 153 153 153 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008023-t006"/>
###xml 153 154 153 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008023-t007">7</xref>
###xml 173 174 173 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 179 180 179 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 214 218 214 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FokI</italic>
###xml 223 227 223 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TaqI</italic>
###xml 338 342 338 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BsmI</italic>
###xml 347 351 347 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApaI</italic>
###xml 163 171 <span type="species:ncbi:9606">patients</span>
Table 7 shows the LD pattern of the FokI, BsmI, ApaI and TaqI alleles with predisposing HLA-DRB1*0301, *0401, *0402 and *0405 (listed as DR3 in tables 5-7) in T1D patients. F and T alleles in the exons 2 and 9 for FokI and TaqI restriction sites respectively show significant interactions (p<0.0002 and 0.0003 respectively). However, for BsmI and ApaI sites both the alleles were significantly associated with predisposing HLA alleles suggesting their null effect.
###end p 59
###begin title 60
Sequence Analysis of HLA DRB1*0301 Promoter Region
###end title 60
###begin p 61
###xml 74 77 74 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 96 99 96 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 264 277 264 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1*0301</italic>
###xml 550 554 550 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Sandelin1">[28]</xref>
###xml 556 564 556 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008023-g002">Figure 2</xref>
###xml 575 589 575 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA- DRB1*0301</italic>
###xml 701 710 701 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DRB1*0301</italic>
###xml 944 957 944 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1*0301</italic>
###xml 1010 1013 1010 1013 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 1021 1030 1021 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DRB1*1501</italic>
###xml 1061 1065 1061 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Ramagopalan1">[26]</xref>
###xml 1115 1128 1115 1128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1*0301</italic>
###xml 19 27 <span type="species:ncbi:9606">patients</span>
Since 85.9% of the patients had DRB1*0301, to study if the interaction of VDR with predisposing HLA alleles was mediated by VDRE present in the promoter region of the allele, we amplified the promoter region of 3 T1D subjects and 3 healthy controls homozygous for HLA-DRB1*0301. Sequencing of the amplified promoter region was done to determine the VDRE variants in the North Indian population. Sequences were aligned using ClustalW2, and the presence of a VDRE was confirmed in-silico using JASPAR_CORE version 3.0 database using default conditions [28]. Figure 2 shows the HLA- DRB1*0301 promoter sequences showing the localization of vitamin D response element (VDRE) in the promoter region of HLA-DRB1*0301 from the 6 subjects. Important regulatory elements like S-box, X-box, Y-box, CCAAY-box, TATA-box and VDRE are highlighted in the figure. Interestingly, the alignment showed exactly the same sequence of VDRE in the promoter region of HLA-DRB1*0301 which has been shown to influence the expression of HLA allele DRB1*1501 recently by Ramagopalan et al [26] suggesting the bases for interaction of VDR with HLA-DRB1*0301.
###end p 61
###begin title 62
Promoter region of HLA- DRB1 was sequenced from 3 subjects suffering from type 1 diabetes and 3 normal healthy individuals homozygous for DRB1*0301.
###end title 62
###begin p 63
###xml 565 569 565 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Emery1">[64]</xref>
###xml 511 516 <span type="species:ncbi:9606">human</span>
The sequence showing important regulatory elements like S-box, X-box, Y-box, CCAAY-box, TATA-box and VDRE are highlighted. Stars (*) in the last row show homology and dots (.) show nucleotide substitution in one or more samples at that particular site and dashes(-) represent gaps inserted to maximize the homology. The ID and A numbers represent the T1D and control samples sequenced respectively. The sequences have been aligned with reference sequence gi|545423|gb|S69987.1| HLA-DRB1 (DRB1*0301) {promoter} [human, lymphoblastoid cell line AVL, Genomic, 416 nt] [64].
###end p 63
###begin title 64
###xml 48 49 48 49 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 50 51 50 51 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
Altered Expression of HLA-DRB1*0301 by 1,25-(OH)2D3 (Calcitriol)
###end title 64
###begin title 65
Flow cytometry
###end title 65
###begin p 66
###xml 0 13 0 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1*0301</italic>
###xml 673 681 673 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008023-g003">Figure 3</xref>
HLA-DRB1*0301 homozygous B-lymphoblastoid cell lines (B-LCL) VAVY (International Histocompatibility Workshop cell line Number IHW09023) and DUCAF (International Histocompatibility Workshop cell line Number IHW09019) were treated with 100 nM of calcitriol (Sigma) for 24 hours and stained with anti-HLA DR-PE antibody (BD Biosciences) to study the expression of HLA-DR on B-LCL cells treated with or without calcitriol and acquired on BD-LSR flowcytometer. The data was analysed using WinMDI 2.9 software. The results showed 1.2-1.3 fold higher expression of HLA-DR in the B-LCLs treated with calcitriol as compared to the vehicle controls in three independent experiments (Figure 3). Two tailed Paired T test shows the difference to be significant with p<0.001 suggesting enhanced expression of HLA-DR in B-LCLs treated with calcitriol as compared to untreated ones.
###end p 66
###begin title 67
Flow cytometric analysis of HLA-DR expression.
###end title 67
###begin p 68
B-LCLs VAVY and DUCAF cells were treated with 100 nM calcitriol or equal volume of alcohol as vehicle control. Both VAVY and DUCAF cells show a significant increase in surface HLA-DR expression as determined by the geometric mean flurescence intensity of staining with HLA-DR-PE antibody. A. The figure shows mean+/-S.E.M. of three independent experiments. Two tailed Paired T test shows the difference to be significant with p<0.001 i.e., enhanced expression of HLA-DR in B-LCLs treated with calcitriol as compared to untreated ones. B: Line graph showing the extent of enhanced HLA-DR expression in three independent expeiments.
###end p 68
###begin title 69
Real Time PCR
###end title 69
###begin p 70
###xml 307 315 303 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 533 546 529 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1*0301</italic>
RNA was extracted from the B-LCLs VAVY and DUCAF after 24 hour treatment with calcitriol and vehicle control, reverse transcribed and real time PCR was performed for HLA-DR to study its expression. The data shows an average of 1.79+/-0.28 (mean+/-S.D. of three independent experiments) fold increase in the HLA-DRB1 transcripts from B-LCL treated with calcitriol as compared to the vehicle control. We also confirmed these results using peripheral blood mononuclear cells (PBMCs) derived from a normal healthy control homozygous for HLA-DRB1*0301 and observed a 1.77 fold increase in expression of HLA-DR when treated with calcitriol as compared to untreated PBMCs.
###end p 70
###begin title 71
Discussion
###end title 71
###begin p 72
###xml 31 32 31 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 41 42 41 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 54 58 54 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FokI</italic>
###xml 63 67 63 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TaqI</italic>
###xml 76 79 76 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 107 120 107 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA DRB1*0301</italic>
###xml 172 181 172 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DRB1*0301</italic>
###xml 203 204 203 204 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 205 206 205 206 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 401 404 397 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Takeuchi1">[6]</xref>
###xml 406 410 402 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Komine1">[29]</xref>
###xml 411 415 407 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Rooney1">[33]</xref>
###xml 496 500 492 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Rigby1">[13]</xref>
###xml 502 506 498 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Skjodt1">[14]</xref>
###xml 529 532 525 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 567 570 563 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 595 599 591 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Ogunkolade1">[34]</xref>
###xml 721 737 717 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FokI, BsmI, ApaI</italic>
###xml 742 746 738 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TaqI</italic>
###xml 761 764 757 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 845 849 841 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FokI</italic>
###xml 925 926 921 922 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 932 933 928 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1011 1014 1007 1010 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATG</italic>
###xml 1088 1089 1084 1085 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 1110 1111 1106 1107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1162 1166 1158 1162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FokI</italic>
###xml 1189 1190 1185 1186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</italic>
###xml 1274 1275 1270 1271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1319 1323 1315 1319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Nejentsev1">[35]</xref>
###xml 1324 1328 1320 1324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Zmuda1">[37]</xref>
###xml 1343 1344 1339 1340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1436 1440 1432 1436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Haussler1">[38]</xref>
###xml 1514 1518 1510 1514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Jurutka1">[39]</xref>
###xml 1531 1532 1527 1528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1692 1696 1688 1692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-vanEtten1">[40]</xref>
###xml 1749 1750 1745 1746 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1768 1771 1764 1767 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MHC</italic>
###xml 1891 1896 1887 1892 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR-F</italic>
###xml 1951 1956 1947 1952 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F-VDR</italic>
###xml 2090 2094 2086 2090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-vanEtten1">[40]</xref>
###xml 479 484 <span type="species:ncbi:9606">human</span>
###xml 1431 1435 <span type="species:ncbi:4456">Apes</span>
In this study we show that the F and the T alleles of FokI and TaqI site of VDR interact with predisposing HLA DRB1*0301 through VDRE present in the promoter region of the DRB1*0301 allele. VDR-1,25-(OH)2D3 complex has been shown to play a significant role in interfering with the signaling of transcription factors (like NFAT, NF-kappaB and AP-1) involved in the regulation of immunomodulatory genes [6], [29]-[33] as well as expression of HLA class-II alleles on monocytes and human bone cells [13], [14]. Polymorphisms in the VDR gene have been shown to influence VDR mRNA and protein levels [34], which in turn may influence the immunomodulatory function of VDR. We have studied four single nucleotide polymorphisms (FokI, BsmI, ApaI and TaqI sites) in the VDR region in T1D and compared them to normal healthy controls. The SNP detected by FokI digestion is the only polymorphisms at the translation start site where a 'T' to 'C' substitution alters the VDR protein in such a way that there are either two ATG start sites separated by six nucleotides or only one start codon if the 'T' is substituted by 'C'. The former gives rise to a restriction site for FokI and is designated as 'f' allele which encodes a 427 amino acid protein, while the latter is designated as 'F' allele encoding a 424 amino acid protein. [35]-[37]. The shorter 'F' allele has been reported to have emerged later after the divergence of hominids from Apes [38] and a higher percentage of the allele suggests an evolutionary advantage [39]. Recently, 'F' allele has also been shown to affect the immune system with a more active immune system for short 'F'-VDR suggesting its role in the immune-mediated diseases [40]. The gene to gene interaction analysis shows allele F and predisposing MHC alleles to have significant interaction suggesting the integrated roles of the MHC alleles in antigen presentation and VDR-F allele in enhanced autoimmune responses since shorter F-VDR has been shown to result in higher NF-kappaB- and NFAT-driven transcription as well as higher IL-12p40 promoter-driven transcription [40].
###end p 72
###begin p 73
###xml 46 48 46 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bb</italic>
###xml 137 141 137 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-McDermott1">[41]</xref>
###xml 177 178 177 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 355 358 355 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B/b</italic>
###xml 426 429 426 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 557 560 557 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 583 587 583 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-McDermott1">[41]</xref>
###xml 588 592 588 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Pani1">[46]</xref>
###xml 667 670 667 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 706 710 706 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Angel1">[47]</xref>
###xml 711 715 711 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Bianco1">[49]</xref>
###xml 746 750 746 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Guo1">[50]</xref>
###xml 811 814 811 814 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 909 913 909 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Ponsonby1">[51]</xref>
###xml 929 930 929 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 939 940 939 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 952 956 952 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FokI</italic>
###xml 961 965 961 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BsmI</italic>
###xml 1082 1088 1082 1088 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TaqI T</italic>
###xml 1214 1217 1214 1217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 1308 1311 1308 1311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 1485 1488 1485 1488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 85 93 <span type="species:ncbi:9606">patients</span>
In the present study, we observed homozygous 'bb' to be significantly reduced in the patients in contrast to a report by McDermott et al [41] in Southern Indian families where 'b' allele was shown to be excessively transmitted to the affected offsprings. This difference could be due to different ethnicity of south and north Indian populations since the B/b polymorphism does not have any functional significance. Individual VDR polymorphisms have been studied in different populations with conflicting reports. Some reports find a positive association of VDR polymorphism with T1D [41]-[46], while there are a considerable number of reports where no association of VDR polymorphism with T1D was observed [47]-[49]. In a meta-analysis Guo et al [50] did not see any evidence of significant association between VDR polymorphism and T1D in either case-control or family transmission. Yet another meta-analysis [51] concluded that F and the B alleles at FokI and BsmI site showed an increased relative risk for T1D as regional winter UVR levels increased, however, the association of TaqI T allele with T1D decreased with winter suggesting that the environmental UVR conditions may influence the association between VDR genotype and T1D risk. Hence, the contradictory reports in the literature with respect to VDR associations in T1D could be due to ethnic differences in the frequencies of different SNPs in different populations, the environmental UVR and the pleiotropic behaviour of VDR.
###end p 73
###begin p 74
###xml 365 369 365 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Guy1">[52]</xref>
###xml 405 409 405 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BsmI</italic>
###xml 437 441 437 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApaI</italic>
###xml 451 455 451 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TaqI</italic>
###xml 497 501 497 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApaI</italic>
###xml 534 538 534 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TaqI</italic>
###xml 582 586 582 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FokI</italic>
###xml 643 653 643 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BsmI, ApaI</italic>
###xml 658 662 658 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TaqI</italic>
###xml 743 747 743 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FokI</italic>
###xml 827 829 827 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FF</italic>
###xml 852 854 852 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ff</italic>
###xml 920 924 920 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBAt</italic>
###xml 931 935 931 935 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fBAT</italic>
###xml 1271 1276 1271 1276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8216;fBAT</italic>
###xml 1375 1379 1375 1379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBAt</italic>
###xml 1709 1713 1707 1711 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBAt</italic>
###xml 1720 1724 1718 1722 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fBAT</italic>
###xml 1862 1866 1860 1864 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fBAT</italic>
###xml 2027 2028 2025 2026 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 2034 2035 2032 2033 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 2147 2151 2145 2149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FokI</italic>
###xml 2156 2160 2154 2158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TaqI</italic>
###xml 2208 2211 2206 2209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 2211 2215 2209 2213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Ogunkolade1">[34]</xref>
###xml 814 822 <span type="species:ncbi:9606">patients</span>
###xml 970 978 <span type="species:ncbi:9606">patients</span>
###xml 1044 1052 <span type="species:ncbi:9606">patients</span>
###xml 1142 1150 <span type="species:ncbi:9606">patients</span>
###xml 1316 1324 <span type="species:ncbi:9606">patients</span>
###xml 1417 1425 <span type="species:ncbi:9606">patients</span>
###xml 1763 1771 <span type="species:ncbi:9606">patients</span>
###xml 1818 1826 <span type="species:ncbi:9606">patients</span>
###xml 1906 1914 <span type="species:ncbi:9606">patients</span>
###xml 2127 2135 <span type="species:ncbi:9606">patients</span>
It is important that all the SNPs of the gene constituting a haplotype be studied as representative of the allele or the so-called "pseudo-allele" as such rather than individual SNPs since it is possible that the 5' and 3' polymorphisms may be functionally linked to each other either through their independent influences on VDR activity or by physical interaction [52]. SHEsis and Famhap analysis showed BsmI site was in strong LD with ApaI site and TaqI site with D' values of 0.91 and 0.93 and ApaI site was also in strong LD with TaqI site with a D' value of 0.97, however, the FokI site was in a very weak linkage disequilibium (LD) with BsmI, ApaI and TaqI sites with D' values of 0.004, 0.01 and 0.04 respectively. The haplotypes, with FokI alleles, however, could still be constructed because 60.2% of the patients had FF genotype and 6.4% had ff genotype. SHEsis analysis in the present study showed haplotype 'FBAt' and 'fBAT' to be significantly increased in patients as compared to controls. Both these haplotypes were increased in patients with less than 18 years as age at onset. However, there was no significant difference in patients with adult age at onset as compared to controls. We also observed a gender-wise distribution of these haplotypes. While 'fBAT' was significantly increased in female patients as compared to all controls and female controls, 'FBAt' was significantly increased in male patients as compared to all controls and male controls. To study the distribution of these haplotypes in the two genders with the age at onset, we divided the males and females into two groups each i.e., with adult onset (above 18 years) and younger onset (</=18 years). Interestingly, both 'FBAt' and 'fBAT' were significantly increased in male patients with younger age at onset and not in the male patients with adult onset of T1D. However, 'fBAT' was significantly increased in female patients in both adult onset as well as younger onset of the disease. These data suggest that different haplotypes with 'F' or 'T' allele may be involved in differential effects on the immune systems in males and females patients since both FokI and TaqI sites have been implicated in transcription of VDR[34].
###end p 74
###begin p 75
###xml 27 47 27 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1*0301, *0401</italic>
###xml 52 57 52 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*0405</italic>
###xml 83 86 83 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Rani1">[2]</xref>
###xml 103 106 103 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MHC</italic>
###xml 203 206 203 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 283 284 283 284 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 397 400 397 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 413 416 413 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 777 780 777 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 824 827 824 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 917 921 917 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Zhao1">[25]</xref>
###xml 1002 1005 1002 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 1021 1057 1021 1057 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DR3 (HLA-DRB1*0301, *0401, *0402</italic>
###xml 1062 1067 1062 1067 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*0405</italic>
###xml 1260 1264 1260 1264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Zhao1">[25]</xref>
###xml 1343 1347 1343 1347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Zhao1">[25]</xref>
###xml 1483 1491 1483 1491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBAT-DR3</italic>
###xml 1493 1501 1493 1501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FbaT-DR3</italic>
###xml 1506 1514 1506 1514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fbaT-DR3</italic>
###xml 1625 1626 1625 1626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 1711 1714 1711 1714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 1752 1753 1752 1753 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1760 1761 1760 1761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</italic>
###xml 1792 1799 1792 1799 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DR3</italic>
###xml 1880 1884 1880 1884 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DR-3</italic>
###xml 1937 1952 1937 1952 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fok, BsmI, ApaI</italic>
###xml 1957 1962 1957 1962 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq 1</italic>
###xml 1972 1979 1972 1979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008023-t007">Table 7</xref>
###xml 2010 2011 2010 2011 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 2023 2027 2023 2027 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FokI</italic>
###xml 2055 2059 2055 2059 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TaqI</italic>
###xml 2116 2123 2116 2123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DR3</italic>
###xml 2140 2141 2140 2141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 2148 2149 2148 2149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 2164 2165 2164 2165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 2172 2173 2172 2173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 2186 2190 2186 2190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BsmI</italic>
###xml 2195 2199 2195 2199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApaI</italic>
###xml 1555 1563 <span type="species:ncbi:9606">patients</span>
We have shown earlier that HLA-DRB1*0301, *0401 and *0405 are predisposing for T1D [2]. Association of MHC class-II alleles with an autoimmune disease could be due to its antigen presenting function and VDR may have a role in regulation of autoimmune responses through VDR -1,25 (OH)2D3 complex. Hence, we sought to study whether interaction of two independently assorting genes i.e. predisposing HLA alleles and VDR alleles have a role to play in the precipitation of the disease. T1D is a complex, multi-factorial disease where individual factors may not show any significant difference, however, when studied in association with other predisposing factors, integration of different factors may be implicated. To study the interaction of two genes which are not linked i.e., VDR (on chromosome 12q 13-14) and predisposing HLA alleles (on chromosome 6p21.3), we used "LD based statistics" as described by Zhao et al [25]. We tested the interaction by comparing the difference in the LD levels between VDR haplotypes and HLA-DR3 (HLA-DRB1*0301, *0401, *0402 and *0405 collectively) between cases and controls. Since there is a possibility of background LD between the two unlinked loci in the population, we used more robust case-control formula as Zhao et al [25] suggest that case-only formula may lead to type 1 error. Moreover, Zhao et al [25] argue that LD based statistics has much higher power in detecting interaction than does the logistic regression. The analysis revealed FBAT-DR3, FbaT-DR3 and fbaT-DR3 to show significant interactions in the patients as compared to controls. It is obvious from these data that 'T' allele is common in all the haplotypes which showed interaction with pre-disposing HLA alleles, while haplotypes with both 'F' and 'f' alleles were associated with HLA-DR3 allele, so to dissect out which of these alleles were actually interacting with DR-3 allele, we applied LD based statistic to individual Fok, BsmI, ApaI and Taq 1 alleles (Table 7) and the data suggested that 'F' allele at FokI site and 'T' allele at the TaqI site show significant interaction with the predisposing HLA-DR3. However, both 'B' and 'b' alleles and 'A' and 'a' alleles at BsmI and ApaI sites respectively showed interaction suggesting their null effect.
###end p 75
###begin p 76
###xml 18 21 18 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 37 40 37 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 84 88 84 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Gross1">[21]</xref>
###xml 90 94 90 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Ogunkolade1">[34]</xref>
###xml 96 100 96 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Gross2">[53]</xref>
###xml 177 180 177 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 196 200 196 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FokI</italic>
###xml 290 293 290 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 318 322 318 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Ogunkolade1">[34]</xref>
###xml 336 340 336 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Gross2">[53]</xref>
###xml 387 390 387 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 411 413 411 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FF</italic>
###xml 426 427 426 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 543 544 543 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</italic>
###xml 642 646 642 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Jurutka1">[39]</xref>
###xml 677 681 677 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Jurutka1">[39]</xref>
###xml 862 866 862 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FokI</italic>
###xml 983 987 983 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-McDermott1">[41]</xref>
###xml 1008 1012 1008 1012 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FokI</italic>
###xml 1017 1021 1017 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TaqI</italic>
###xml 1121 1124 1121 1124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MHC</italic>
###xml 1134 1138 1134 1138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FokI</italic>
###xml 1143 1147 1143 1147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TaqI</italic>
###xml 1191 1194 1191 1194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 1232 1236 1232 1236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Uitterlinden1">[54]</xref>
###xml 1485 1489 1485 1489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Uitterlinden1">[54]</xref>
###xml 1498 1499 1498 1499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1510 1514 1510 1514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FokI</italic>
###xml 1519 1520 1519 1520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 1531 1535 1531 1535 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TaqI</italic>
An association of VDR genotypes with VDR mRNA and VDR protein has been demonstrated [21], [34], [53] in peripheral blood mononuclear cells providing functional relevance to the VDR polymorphisms. FokI and TaqI genotypes were observed to be independent determinants of insulin secretion and VDR mRNA and protein levels [34]. Gross et al [53] showed an increased transcription rate of the VDR gene in cells with 'FF' genotype. 'F' allele which encodes the shorter protein has been shown to be transcriptionally 1.5 to 2.5 fold more active than 'f' allele and has also been shown to associate more avidly with Transcription factor II B (TF IIB) [39]. Interestingly, Jurutka et al [39] show that vitamin-D3 mediated transcription requires specific physical interaction of VDR with TF IIB which involves both C and N terminal domains in the receptor. Moreover, while FokI site is situated in the N-terminal end of the VDR molecule, the ligand binding domain is situated in its C-terminal [41], which explains why FokI and TaqI sites may be playing detrimental roles in the manifestation of T1D in the presence of predisposing MHC alleles. FokI and TaqI genotypes have been shown to contribute to VDR mRNA and protein levels independently[54]. While the promoter has been shown to regulate production of mRNA, the 3'UTR is involved in stability/degradation of mRNA, and their interaction or combined effects may regulate the net availability of the mRNA for translation into the VDR protein [54]. Hence, F allele of FokI and T allele of TaqI along with predisposing MHC alleles play an integrated role in the autoimmune responses in T1D.
###end p 76
###begin p 77
###xml 14 20 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR-FF</italic>
###xml 171 173 171 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ff</italic>
###xml 183 187 183 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-vanEtten1">[40]</xref>
###xml 232 233 232 233 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 234 235 234 235 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 331 335 331 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Uitterlinden1">[54]</xref>
###xml 471 472 471 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 479 480 479 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 719 720 719 720 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 721 722 721 722 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1028 1029 1028 1029 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1116 1117 1116 1117 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1118 1119 1118 1119 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1137 1140 1137 1140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Evans1">[4]</xref>
###xml 1245 1248 1241 1244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Bhalla1">[7]</xref>
###xml 1249 1252 1245 1248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Cippitelli1">[9]</xref>
###xml 1254 1258 1250 1254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-DAmbrosio1">[11]</xref>
Functionally, VDR-FF individuals have been shown to produce more IL-12p40 and IL-12p35 and even the IL-12 protein is higher in these individuals as compared to those with ff genotype [40]. On the other hand, the VDR ligand 1,25 (OH)2D3 has been shown to inhibit lymphocyte proliferation and production of IFN-gamma, IL-2 and IL-12 [54]. Hence, in the present scenario, while predisposing MHC alleles may be involved in auto-antigen presentation, the VDR haplotypes with 'F' and 'T' alleles may have a role in increased amount of VDR protein resulting in increased IL-12 production which in turn may lead to other downstream pro-inflammatory immune responses against auto-antigens in T1D. And administration of 1,25-(OH)2D3 in type 1 diabetes may be able to inhibit these pro-inflammatory immune responses by binding to VDR which induces conformational changes in VDR, promoting its heterodimerization with Retinoid X Receptor (RXR), followed by translocation of this complex into the nucleus which in turn binds to the vitamin D3 responsive elements (VDRE) or the DNA binding domains in promoter regions of 1,25-(OH)2D3 responsive genes [4], thereby down regulating transcription of the pro-inflammatory cytokines like IL-2, IFN-gamma and IL-12 [7]-[9], [11], thus delaying the pathogenesis of type 1 diabetes.
###end p 77
###begin p 78
###xml 74 87 74 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1*0301</italic>
###xml 188 196 188 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 242 246 242 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Ramagopalan1">[26]</xref>
###xml 312 315 312 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 426 430 426 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Ramagopalan1">[26]</xref>
###xml 572 575 572 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Takeuchi1">[6]</xref>
###xml 667 680 667 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1*0301</italic>
###xml 727 736 727 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DRB1*0301</italic>
###xml 855 868 855 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA DRB1*1501</italic>
###xml 898 902 898 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Ramagopalan1">[26]</xref>
###xml 922 926 922 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Ramagopalan1">[26]</xref>
###xml 1004 1013 1004 1013 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DRB1*1501</italic>
###xml 1181 1189 1181 1189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 1241 1245 1241 1245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Ramagopalan1">[26]</xref>
###xml 1294 1307 1294 1307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1*0301</italic>
###xml 1459 1462 1459 1462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 1468 1477 1468 1477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DRB1*0301</italic>
###xml 1600 1603 1600 1603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 1716 1717 1716 1717 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1718 1719 1718 1719 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1917 1921 1917 1921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Mathieu1">[15]</xref>
###xml 1922 1926 1922 1926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Zella1">[18]</xref>
###xml 2041 2045 2041 2045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Hypponen1">[19]</xref>
###xml 2096 2109 2096 2109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA DRB1*0301</italic>
###xml 2164 2177 2164 2177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1*0301</italic>
###xml 2728 2732 2728 2732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Ramagopalan1">[26]</xref>
###xml 3431 3444 3429 3442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1*0301</italic>
###xml 3505 3509 3503 3507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Ramagopalan1">[26]</xref>
###xml 3658 3667 3656 3665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DRB1*0301</italic>
###xml 3690 3698 3688 3696 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INS-VNTR</italic>
###xml 3740 3742 3738 3740 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 3793 3796 3791 3794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Rani1">[2]</xref>
###xml 3798 3806 3796 3804 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INS-VNTR</italic>
###xml 3939 3943 3937 3941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Pugliese1">[55]</xref>
###xml 3945 3949 3943 3947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Vafiadis1">[56]</xref>
###xml 4193 4196 4191 4194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 4233 4236 4231 4234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 4318 4319 4316 4317 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 4320 4321 4318 4319 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 4348 4356 4346 4354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in-utero</italic>
###xml 4432 4441 4430 4439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DRB1*0301</italic>
###xml 1260 1268 <span type="species:ncbi:9606">patients</span>
###xml 1734 1738 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 1942 1948 <span type="species:ncbi:9606">humans</span>
###xml 3751 3759 <span type="species:ncbi:9606">patients</span>
Additionally, presence of VDRE in the promoter region of the predisposing HLA-DRB1*0301 may also have a significant role in manifestation of the disease since a direct interaction between HLA-DRB1 and vitamin D has been demonstrated recently [26]. VDRE is shown to have subtle sequence differences and different HLA alleles may have different VDRE sequences in their promoter regions influencing the expression of HLA alleles [26]. Gene expression of vitamin D regulated genes has been shown to be influenced by these subtle sequence differences within the classical VDRE [6]. Hence, we sequenced the promoter region of normal and affected individuals homozygous for HLA-DRB1*0301 and discovered that VDRE sequence observed in DRB1*0301 promoters from North Indians is homologous to the VDRE sequence which had been shown to up-regulate the expression of HLA DRB1*1501 allele in Multiple Sclerosis [26]. Ramagopalan et al [26] showed that the VDRE corresponding to the Multiple Sclerosis (MS) associated DRB1*1501 haplotype bound to recombinant VDR/RXR with high specificity in vitro in contrast to relatively lower affinity for the VDRE variants observed in the non-MS associated HLA-DRB1 haplotypes which were not responsive to vitamin D3 [26]. 85.9% of the patients in the present study had HLA-DRB1*0301 with 27.7% being homozygous and the rest heterozygous with DRB1*04 or any other alleles (data not shown). These data suggested that the interaction of VDR with DRB1*0301 is through the VDRE present in the promoter region of the HLA allele. Interestingly, both Multiple Sclerosis and T1D have HLA as the main susceptibility locus and vitamin D a strong environmental element since supplementation of 1,25-(OH)2D3 analog in NOD mice before the onset of Insulitis, has been effectively shown to prevent the disease progression. However, this treatment was ineffective when Insulitis had already been established [15]-[18]. Similarly, in humans, vitamin D supplementation in early childhood has been shown to reduce the incidence of T1D [19]. To study whether the interaction of VDR with the HLA DRB1*0301 is through VDRE present in the promoter region of the HLA-DRB1*0301, we stimulated the International Histocomopatibility Workshop's DRB1*0301 homozygous B-lymphoblastoid cell line VAVY (B-LCL IHW09023) and DUCAF (B-LCL IHW09019) with 100 nM of calcitriol and checked for the expression of DR using flow cytometry and real time PCR. The B-LCLs showed 1.2-1.3 fold enhanced expression on flow cytometry, probably because of constitutively high levels of HLA- DR expression on the cell lines tested. However, this enhanced difference was statistically significant on two tailed paired T test (p<0.001). Ramagopalan et al [26] have also shown 1.3 fold increase in expression of HLA-DRB1 in DRB1*15 homozygous cell line PGF on addition of calcitriol and they too found it to be statistically significant. Interestingly, however, real time PCR showed 1.8+/-0.28 fold increase in the HLA-DR transcripts. Thus, the enhanced expression of HLA-DR on the B-LCLs stimulated with calcitriol as compared to the unstimulated one confirms that indeed the interaction of VDR with HLA-DRB1*0301 is occurring through the VDRE present in the promoter region of the gene. Based on the earlier studies and the present data one can speculate that in the absence of required amount of Vitamin D in early life in the predisposed individuals with HLA-DRB1*0301, the expression of the allele may be impaired in the thymus [26] resulting in escape from thymic deletion of autoreactive T cells leading to T1D manifestations. We have shown earlier that simultaneous presence of DRB1*0301 along with homozygous INS-VNTR class-I was significantly increased (p<10-8) in T1D patients, giving a relative risk of 70.81 [2]. INS-VNTR class-I has also been shown to be associated with lower expression of Insulin in thymii of fetuses as compared to Class-III alleles [55], [56] which may be responsible for poor thymic education for insulin resulting in autoimmunity against pancreatic beta cells. The present study provides additional evidence based on the statistically significant interaction between the predisposing HLA allele and high producer alleles of VDR which may be detrimental for the manifestation of T1D in the absence of 1,25-(OH)2D3 in early childhood and/or in-utero and this interaction is mediated by VDRE present in the promoter region of DRB1*0301.
###end p 78
###begin title 79
Materials and Methods
###end title 79
###begin p 80
###xml 81 89 <span type="species:ncbi:9606">patients</span>
###xml 202 207 <span type="species:ncbi:9606">Human</span>
Genomic DNA was extracted using a standard protocol from 10 ml of blood from T1D patients and healthy controls from the same ethnic background after obtaining informed written consent and Institutional Human Ethics Committee's approval from both All India Institute of Medical Sciences (AIIMS) and National Institute of Immunology (NII).
###end p 80
###begin p 81
###xml 162 165 162 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 426 429 426 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Kumar1">[3]</xref>
###xml 431 435 431 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Goswami1">[57]</xref>
###xml 821 825 821 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-1">[58]</xref>
###xml 1123 1126 1123 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Kumar1">[3]</xref>
###xml 185 193 <span type="species:ncbi:9606">patients</span>
###xml 384 392 <span type="species:ncbi:9606">patients</span>
###xml 586 594 <span type="species:ncbi:9606">patients</span>
###xml 619 627 <span type="species:ncbi:9606">patients</span>
###xml 926 934 <span type="species:ncbi:9606">patients</span>
236 T1D subjects and 197 normal healthy controls based in Delhi, originally from three states of North India, Uttar Pradesh, Haryana and Punjab, were studied for VDR polymorphisms. The patients studied in the current study were recruited from 'Type 1 Diabetes Clinic' at All India Institute of Medical Sciences, New Delhi, India, in a consecutive manner from 2004-2008. Most of these patients were part of our earlier studies [3], [57] and were recruited based on their availability in follow up in the clinic and informed consent and were representative of a general population of T1D patients in North India. All the patients were carefully assessed (by RG) and categorized as type 1, type 2 and fibrocalculous pancreatopathy according to the recent classification of the American Diabetes Association expert committee [58]. All of the subjects included in the study required insulin for glycemic control. Insulin requiring patients with fibrocalculous pancreatopathy and subjects with diabetes in whom glycemic control was achieved with diet and oral anti-diabetic drug were excluded from the study as described earlier [3]. The T1D group consisted of 105 females with the mean age at onset 14.74+/-7.57 and 131 males with a mean age of onset 16.89+/-7.25. The control group consisted of 81 females and 116 males with a mean age of 30.1+/-10.2.
###end p 81
###begin p 82
###xml 1346 1355 1346 1355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DRB1*0301</italic>
###xml 238 246 <span type="species:ncbi:9606">patients</span>
###xml 1009 1016 <span type="species:ncbi:9606">patient</span>
Normal healthy controls from the same ethnic background with no history (of self or family) of any autoimmune or infectious diseases were included in the study. They represent the same source population because the controls too, like the patients, belonged to three states of North India, Uttar Pradesh, Haryana and Punjab. The controls were the students, scholars and employees of NII and AIIMS who belonged to these three states. They were not selected in particular but were random individuals who gave informed consent to draw blood and did not have any history of infectious or autoimmune diseases. Controls were not clinically tested; however, they were asked if they had any infectious, autoimmune or any other disease. Only healthy individuals with no disease, symptoms of a disease or family history of any autoimmune or infectious disease, were included in the study. The response rate was about 85%. There was no statistically significant difference between the numbers of Males and Females in the patient and the control group. Higher age group of controls were, however, preferred to rule out their possibility of developing T1D at a later date after the collection of their blood samples as normal healthy controls. Since the control samples have been collected over a period of 5-6 years, all the controls who had the predisposing DRB1*0301 allele and were below the age of 30 years at the time of blood collection have been followed up till the date of analysis to make sure that they did not develop diabetes.
###end p 82
###begin title 83
###xml 22 25 22 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
Genotypic Analysis of VDR Polymorphisms
###end title 83
###begin p 84
###xml 128 144 128 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FokI, BsmI, ApaI</italic>
###xml 150 154 150 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TaqI</italic>
###xml 176 180 176 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Faraco1">[23]</xref>
###xml 182 186 182 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Hustmyer1">[59]</xref>
###xml 297 298 293 294 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 376 379 372 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
###xml 726 738 718 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008023-g001">Figures 1A&#8211;D</xref>
###xml 1027 1039 1019 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008023-g001">figures 1A&#8211;D</xref>
The genotypes for the four SNPs were determined by PCR amplification and restriction digestion of the PCR products with enzymes FokI, BsmI, ApaI, and TaqI as described earlier [23], [59] Briefly, 500 ng of DNA was amplified in 5 microl of 10X Thermo Pol reaction buffer supplemented with 2 mM MgSO4 (New England Biolabs), 5 pm of each primers, 0.25 mM of dNTPs, and 1.25 U of Taq DNA Polymerase (New England Biolabs), under standard conditions for 35 cycles in Perkin Elmer 2700 thermocycler. 1% agarose gel was run to confirm the amplification. To determine the presence of restriction site within an amplified product, a 5 microl aliquot of respective PCR product was digested with the respective restriction endonucleases. Figures 1A-D show the sizes of the restriction fragments obtained after digestion with the respective enzymes, the primers, their annealing temperatures for the PCRs and the temperatures at which restriction digestion was carried out. The interpretation of restriction fragments were done as shown in figures 1A-D.
###end p 84
###begin title 85
HLA-DRB1 Polymorphism
###end title 85
###begin p 86
###xml 11 19 11 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 153 157 153 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DRB1</italic>
###xml 296 299 296 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Rani1">[2]</xref>
###xml 301 305 301 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-FernandezVina1">[60]</xref>
###xml 307 311 307 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Rani2">[61]</xref>
###xml 514 516 514 516 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 538 542 538 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DRB1</italic>
###xml 553 561 553 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DR2, DR4</italic>
###xml 566 570 566 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DR52</italic>
###xml 54 62 <span type="species:ncbi:9606">patients</span>
###xml 89 96 <span type="species:ncbi:9606">patient</span>
Alleles of HLA-DRB1 locus were determined for 233 T1D patients and 191 controls. For 100 patient samples and 94 controls samples, the second exon of the DRB1 gene was PCR amplified using standard conditions and hybridized with sequence specific oligonucleotide probes (SSOP) as described earlier [2], [60], [61]. The PCR products were run on 1% agarose gel to check for amplification. The amplified PCR products were dot blotted on Zeta probe membranes (Biorad), UV cross-linked (Syngene, USA) and hybridized with 32P- labeled probes for DRB1- generic, DR2, DR4 and DR52- associated alleles.
###end p 86
###begin p 87
###xml 187 190 187 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Rani1">[2]</xref>
###xml 267 270 263 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
###xml 902 905 878 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 1346 1352 1322 1328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DR</italic>
###xml 22 30 <span type="species:ncbi:9606">patients</span>
For the remaining 133 patients and 97 control samples a Labtype SSO kit from One Lambda, (Canoga Park, CA, USA) was used according to the manufacturer's instructions as described earlier [2]. Briefly, 40 ng of DNA was amplified in master mix, primers and 2 microl of Taq DNA polymerase in Perkin Elmer 2700 thermal cycler. The amplified product was run on 1% agarose gel to confirm amplification. 5 microl of amplified product was hybridized with appropriate amount of multiplex beads conjugated with oligonucleotide probes, in hybridization buffer at 60degreesC for 15 minutes followed by washing and incubation with 50 microl 1X SAPE solution (Steptavidin Phycoerythin) at 60degreesC for 5 minutes. Fluorescence of the labeled beads was acquired on Luminex 2.2 flow cytometer (Luminex corporation, Austin, TX). Acquired data was analysed using Labtype software provided by One Lambda for analysis of HLA alleles. Some of these samples that were typed using PCR-SSOP earlier were re-typed using Luminex method to study the concordance using Luminex multiplex beads conjugated with oligonucleotide probes, since this was a new method being adopted in the lab to avoid using radioactivity. With 98% concordance between the two methods, Luminex method was used for the rest of the samples. A few samples were typed a second time using Luminex, for HLA-DR alleles, just to confirm the reproducibility.
###end p 87
###begin title 88
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
HLA-DRB1 Promoter Sequencing
###end title 88
###begin p 89
###xml 18 22 18 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DRB1</italic>
###xml 115 123 115 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 218 231 218 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1*0301</italic>
###xml 269 292 269 292 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TTTCAGAAGAGGACCTT-3&#8242;</named-content>
###xml 297 321 297 321 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- CTTACGTCGGGTGTCCC-3&#8242;</named-content>
###xml 321 325 321 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Louis1">[62]</xref>
###xml 433 434 429 430 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 895 921 885 911 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ATACAGCATCTCTGACCAGC-3&#8242;</named-content>
###xml 923 947 913 937 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TCAGCACCATCAGTGTCA-3&#8242;</named-content>
###xml 1104 1108 1094 1098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Sandelin1">[28]</xref>
Sequencing of the DRB1 promoter region was done to determine the VDRE variants in the North Indian population. The HLA-DRB1 promoter region was amplified from 3 T1D subject samples and 3 control samples homozygous for HLA-DRB1*0301 using the primers described earlier, 5'-TTTCAGAAGAGGACCTT-3' and 5'- CTTACGTCGGGTGTCCC-3'[62]. Briefly, 100 ng of DNA was amplified in 2.5 microL of 10X standard Taq Buffer, supplemented with 3 mM MgCl2 (New England Biolabs), 2 pmoles of each primer, 0.25 mM dNTPs, and 1.25U of Taq DNA polymerase (New England Biolabs), under standard conditions at 54degreesC annealing, for 35 cycles in Eppendorf Mastercycler Gradient. Sequencing (using Sanger's di-deoxy chain termination method) of the PCR products was performed using primers internal to the amplification primers which were designed using NCBI primer blast. The sequences of the internal primers used are: 5'-ATACAGCATCTCTGACCAGC-3', 5'-TCAGCACCATCAGTGTCA-3'. Sequences were aligned using ClustalW2, and the presence of a VDRE was confirmed in-silico using JASPAR_CORE version 3.0 database using default conditions [28].
###end p 89
###begin title 90
Expression Analysis Using Flow Cytometry and Real Time PCR
###end title 90
###begin p 91
###xml 0 14 0 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1-*0301</italic>
###xml 248 249 242 243 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 175 181 <span type="species:ncbi:9913">bovine</span>
HLA-DRB1-*0301 homozygous B-lymphoblastoid cell line (B-LCL IHW09023) VAVY and DUCAF (B-LCL IHW09019) were cultured in RPMI 1640 with L-glutamine, supplemented with 15% fetal bovine serum and 100 nM sodium pyruvate at 37degreesC in humidified 5% CO2. Cells were incubated with Calcitriol (Sigma) at a final concentration of 100 nM for 24 hours from a 10 microM stock in ethanol. Control cells were treated with the same volume of absolute ethanol alone.
###end p 91
###begin title 92
Flow Cytometry
###end title 92
###begin p 93
###xml 103 104 103 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 40 45 <span type="species:ncbi:9606">human</span>
Flow cytometry was performed using anti-human HLA-DR antibody conjugated with PE (BD biosciences). 7x105Cells were stained with anti-HLA-DR antibody as per manufacturer's recommendations. Briefly, the cells were washed with Dulbecco's Phosphate buffered saline (DPBS) twice and resuspended in 100 microl of staining buffer containing 0.5% BSA in DPBS. To this 10 microl of anti-DR antibody-PE was added and incubated on ice for 30 minutes. The cells were washed with 0.5% BSA in DPBS, fixed in 2% paraformaldehyde for 10 minutes on ice and acquired on a BD-LSR flow cytometer. Data analysis was performed on Win-MDI 2.9 software.
###end p 93
###begin title 94
Real-Time Analysis
###end title 94
###begin p 95
Total RNA was isolated from cells using Trizol (Invitrogen) method. The RNA was purified using Qiagen RNeasy Mini column purification kit, and reverse transcribed using Superscript III First Strand Kit (Invitrogen). Real Time PCR analysis was performed on the ABI 7000 cycler (95degreesC 10 min Activation, 40 cycles: 95degreesC 15 secs Denaturation, 60degreesC 1 min Anneling/Extension), using Maxima SYBR Green qPCR Master Mix (Fermentas) with the following primers:
###end p 95
###begin p 96
###xml 19 45 19 45 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; CGAAAGCATTTGCCAAGAAT 3&#8242;</named-content>
18s r RNA: Forward 5' CGAAAGCATTTGCCAAGAAT 3'
###end p 96
###begin p 97
###xml 8 34 8 34 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; AGTCGGCATCGTTTATGGTC 3&#8242;</named-content>
Reverse 5' AGTCGGCATCGTTTATGGTC 3'
###end p 97
###begin p 98
###xml 18 44 18 44 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; TTAAGCTGCCACAAGAAACG 3&#8242;</named-content>
HLA-DRB1: Forward 5' TTAAGCTGCCACAAGAAACG 3'
###end p 98
###begin p 99
###xml 8 34 8 34 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; TGTTCTCCAGCATGGTGTGT 3&#8242;</named-content>
Reverse 5' TGTTCTCCAGCATGGTGTGT 3'
###end p 99
###begin p 100
###xml 343 356 339 344 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#916;&#916;Ct</sup>
Expression level changes were calculated as fold-change in the level of transcript between treated and untreated samples and normalized to 18s rRNA levels. DeltaCt values were obtained by subtracting the average Ct values of triplicate SYBR green assays for 18s rRNA from that of the corresponding HLA-DR. Fold change was calculated by using 2-DeltaDeltaCt, where DeltaDeltaCt represents DeltaCt of treated - DeltaCt of untreated control.
###end p 100
###begin title 101
Statistical Analysis
###end title 101
###begin p 102
###xml 446 450 446 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Rani3">[63]</xref>
###xml 543 547 543 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Shi1">[27]</xref>
###xml 648 652 648 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Shi1">[27]</xref>
###xml 148 155 <span type="species:ncbi:9606">patient</span>
###xml 604 612 <span type="species:ncbi:9606">patients</span>
Chi-Square test or Fisher's exact test (whenever the numbers were five or less), were used to determine the significance of differences between the patient and control groups. p values were corrected using Boneferroni's correction by multiplying the p values with the number of alleles tested for the locus. Odds ratios were calculated using Woolf's method, with Haldane's modification wherever the numbers were five or less as described earlier [63]. Further, the Haplotype analysis was done using the SHEsis software freely available at (). [27] Hardy-Weinberg equilibrium was also calculated for both patients and controls using SHEsis software [27]. Additionally, Famhap () was used to confirm the frequencies of the haplotypes. Since both Famhap and SHEsis were giving similar results, we carried out the rest of the analysis using SHEsis only.
###end p 102
###begin p 103
###xml 72 76 72 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Zhao1">[25]</xref>
Interaction of two unlinked loci was tested using "LD based statistics" [25] using the following formulae
###end p 103
###begin p 104
###xml 11 12 7 8 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
Where deltaA is the measure of LD between two unlinked loci a and b in cases and is calculated as
###end p 104
###begin p 105
###xml 7 9 7 9 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ab</sub>
###xml 102 109 102 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DR3</italic>
###xml 118 121 118 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 145 146 145 146 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sub>
###xml 211 212 211 212 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sub>
Where Pab is the observed 'haplotype' frequency of alleles a and b at two unlinked loci (in this case HLA-DR3 and the VDR haplotype/allele) and Pa is the gene frequency of the concerned allele at one locus and Pb is the gene frequency of the unlinked allele on the other locus. Here the word 'haplotype' does not necessarily mean that they are on the same chromosome as conventionally thought, rather simultaneously present alleles of two unlinked loci which may be associated with each other.
###end p 105
###begin p 106
###xml 15 16 11 12 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
Similarly deltaN is the measure of LD between two unlinked loci a and b in controls.
###end p 106
###begin p 107
###xml 1 2 1 2 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
###xml 8 9 8 9 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 44 52 <span type="species:ncbi:9606">patients</span>
VA and VN are the estimators of variance in patients and controls respectively and are calculated as:
###end p 107
###begin p 108
###xml 1 2 1 2 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
###xml 8 9 8 9 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</sub>
###xml 46 54 <span type="species:ncbi:9606">patients</span>
NA and NG are the number of samples tested in patients and control groups respectively.
###end p 108
###begin p 109
###xml 68 69 66 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 69 72 67 70 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(1)</sub>
###xml 160 164 158 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008023-Zhao1">[25]</xref>
The test Statistic T1 is asymptotically distributed as a central chi2(1) distribution under the null hypotheses of no interaction between the two unlinked loci [25].
###end p 109
###begin p 110
We are thankful to Yong Yong Shi for providing the SHEsis program () for haplotype analysis Authors are thankful to the Fred Hutchinson Cancer Research Center IHWG Cell and Gene Bank for providing HLA-DRB1*0301 homozygous lymphoblastoid Cell lines for studies showing effect of vitamin D on HLA-DR expression.
###end p 110
###begin title 111
References
###end title 111
###begin article-title 112
###xml 21 29 <span type="species:ncbi:9606">children</span>
Incidence of IDDM in children in urban population in southern India. Madras IDDM Registry Group Madras, South India.
###end article-title 112
###begin article-title 113
Molecular basis of predisposition to develop type 1 diabetes mellitus in North Indians.
###end article-title 113
###begin article-title 114
###xml 120 128 <span type="species:ncbi:9606">patients</span>
Association and interaction of the TNF-alpha gene with other pro- and anti-inflammatory cytokine genes and HLA genes in patients with type 1 diabetes from North India.
###end article-title 114
###begin article-title 115
The steroid and thyroid hormone receptor superfamily.
###end article-title 115
###begin article-title 116
1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells.
###end article-title 116
###begin article-title 117
Nuclear factor of activated T cells (NFAT) as a molecular target for 1alpha,25-dihydroxyvitamin D3-mediated effects.
###end article-title 117
###begin article-title 118
1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation.
###end article-title 118
###begin article-title 119
Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor.
###end article-title 119
###begin article-title 120
Vitamin D3: a transcriptional modulator of the interferon-gamma gene.
###end article-title 120
###begin article-title 121
Immunomodulatory role of 1,25-dihydroxyvitamin D3.
###end article-title 121
###begin article-title 122
Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene.
###end article-title 122
###begin article-title 123
1,25-dihydroxyvitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-beta 1 and IL-4.
###end article-title 123
###begin article-title 124
###xml 14 19 <span type="species:ncbi:9606">human</span>
Regulation of human monocyte HLA-DR and CD4 antigen expression, and antigen presentation by 1,25-dihydroxyvitamin D3.
###end article-title 124
###begin article-title 125
###xml 70 75 <span type="species:ncbi:9606">human</span>
Constitutive and inducible expression of HLA class II determinants by human osteoblast-like cells in vitro.
###end article-title 125
###begin article-title 126
###xml 51 55 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice.
###end article-title 126
###begin article-title 127
###xml 41 45 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3.
###end article-title 127
###begin article-title 128
###xml 157 161 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
1,25-Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in nonobese diabetic mice.
###end article-title 128
###begin article-title 129
###xml 72 76 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Oral administration of 1,25-dihydroxyvitamin D3 completely protects NOD mice from insulin-dependent diabetes mellitus.
###end article-title 129
###begin article-title 130
Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study.
###end article-title 130
###begin article-title 131
Current understanding of the molecular actions of vitamin D.
###end article-title 131
###begin article-title 132
###xml 176 181 <span type="species:ncbi:9606">women</span>
The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women.
###end article-title 132
###begin article-title 133
Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin.
###end article-title 133
###begin article-title 134
###xml 23 28 <span type="species:ncbi:9606">human</span>
ApaI dimorphism at the human vitamin D receptor gene locus.
###end article-title 134
###begin article-title 135
Vitamin D receptor 3'-untranslated region polymorphisms: lack of effect on mRNA stability.
###end article-title 135
###begin article-title 136
Test for interaction between two unlinked loci.
###end article-title 136
###begin article-title 137
Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D.
###end article-title 137
###begin article-title 138
SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci.
###end article-title 138
###begin article-title 139
JASPAR: an open-access database for eukaryotic transcription factor binding profiles 10.1093/nar/gkh012.
###end article-title 139
###begin article-title 140
The action of a novel vitamin D3 analogue, OCT, on immunomodulatory function of keratinocytes and lymphocytes.
###end article-title 140
###begin article-title 141
A two-hit mechanism for vitamin D3-mediated transcriptional repression of the granulocyte-macrophage colony-stimulating factor gene: vitamin D receptor competes for DNA binding with NFAT1 and stabilizes c-Jun.
###end article-title 141
###begin article-title 142
###xml 58 63 <span type="species:ncbi:9606">human</span>
Down-regulation of NF-kappa B protein levels in activated human lymphocytes by 1,25-dihydroxyvitamin D3.
###end article-title 142
###begin article-title 143
Activity of monomeric, dimeric, and trimeric flavonoids on NO production, TNF-alpha secretion, and NF-kappaB-dependent gene expression in RAW 264.7 macrophages.
###end article-title 143
###begin article-title 144
Novel NFAT sites that mediate activation of the interleukin-2 promoter in response to T-cell receptor stimulation.
###end article-title 144
###begin article-title 145
Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians.
###end article-title 145
###begin article-title 146
Comparative high-resolution analysis of linkage disequilibrium and tag single nucleotide polymorphisms between populations in the vitamin D receptor gene.
###end article-title 146
###begin article-title 147
###xml 152 157 <span type="species:ncbi:9606">women</span>
A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women.
###end article-title 147
###begin article-title 148
Molecular epidemiology of vitamin D receptor gene variants.
###end article-title 148
###begin article-title 149
The nuclear vitamin D receptor: biological and molecular regulatory properties revealed.
###end article-title 149
###begin article-title 150
###xml 30 35 <span type="species:ncbi:9606">human</span>
The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB.
###end article-title 150
###begin article-title 151
The vitamin D receptor gene FokI polymorphism: functional impact on the immune system.
###end article-title 151
###begin article-title 152
Allelic variation in the vitamin D receptor influences susceptibility to IDDM in Indian Asians.
###end article-title 152
###begin article-title 153
Vitamin D receptor gene polymorphisms influence susceptibility to type 1 diabetes mellitus in the Taiwanese population.
###end article-title 153
###begin article-title 154
Vitamin D receptor polymorphism and susceptibility to type 1 diabetes in the Dalmatian population.
###end article-title 154
###begin article-title 155
Vitamin D receptor gene polymorphism affects onset pattern of type 1 diabetes.
###end article-title 155
###begin article-title 156
The study of CTLA-4 and vitamin D receptor polymorphisms in the Romanian type 1 diabetes population.
###end article-title 156
###begin article-title 157
Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans.
###end article-title 157
###begin article-title 158
Vitamin D receptor polymorphism and susceptibility to type 1 diabetes in Chilean subjects: a case-parent study.
###end article-title 158
###begin article-title 159
Vitamin D receptor polymorphisms: no association with type 1 diabetes in the Finnish population.
###end article-title 159
###begin article-title 160
Vitamin D receptor polymorphisms: are they really associated with type 1 diabetes?
###end article-title 160
###begin article-title 161
Meta-analysis of vitamin D receptor polymorphisms and type 1 diabetes: a HuGE review of genetic association studies.
###end article-title 161
###begin article-title 162
Variation in associations between allelic variants of the vitamin D receptor gene and onset of type 1 diabetes mellitus by ambient winter ultraviolet radiation levels: a meta-regression analysis.
###end article-title 162
###begin article-title 163
Vitamin D receptor gene polymorphisms and breast cancer risk.
###end article-title 163
###begin article-title 164
The vitamin D receptor gene start codon polymorphism: a functional analysis of FokI variants.
###end article-title 164
###begin article-title 165
Genetics and biology of vitamin D receptor polymorphisms.
###end article-title 165
###begin article-title 166
###xml 39 44 <span type="species:ncbi:9606">human</span>
The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes.
###end article-title 166
###begin article-title 167
###xml 22 27 <span type="species:ncbi:9606">human</span>
Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus.
###end article-title 167
###begin article-title 168
Prevalence of thyroid autoimmunity in sporadic idiopathic hypoparathyroidism in comparison to type 1 diabetes and premature ovarian failure.
###end article-title 168
###begin article-title 169
Report of the expert committee on the diagnosis and classification of diabetes mellitus.
###end article-title 169
###begin article-title 170
###xml 48 53 <span type="species:ncbi:9606">human</span>
ApaI, BsmI, EcoRV and TaqI polymorphisms at the human vitamin D receptor gene locus in Caucasians, blacks and Asians.
###end article-title 170
###begin article-title 171
Alleles at four HLA class II loci determined by oligonucleotide hybridization and their associations in five ethnic groups.
###end article-title 171
###begin article-title 172
Diversity of HLA-DR2 in North Indians: the changed scenario after the discovery of DRB1*1506.
###end article-title 172
###begin article-title 173
Polymorphism in the regulatory region of HLA-DRB genes correlating with haplotype evolution.
###end article-title 173
###begin article-title 174
Associations between HLA class II alleles in a North Indian population.
###end article-title 174
###begin article-title 175
The different level of expression of HLA-DRB1 and -DRB3 genes is controlled by conserved isotypic differences in promoter sequence.
###end article-title 175
###begin p 176
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 176
###begin p 177
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: The project was funded in part by a grant from Department of Science and Technology (DST), Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India and partly by Core funds of National Institute of Immunology, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 177

